Atlas Trials

Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes

Clinical trial NCT06129526 · UNKNOWN

Trial details

NCT number
NCT06129526
Sponsor
University of Ioannina
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Type 2HypertriglyceridemiaDiabetes Mellitus
Start date
2023-12-01
Primary completion
2024-09-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.